the aid library

Cervical Cancer in Women with HIV in Latin America and the Caribbean: Update and Steps Towards Elimination

PAHO, ICW-LATINA PAHO (2020) C_WHO

This fact sheet is based on a systematic review of the literature on HPV and cervical cancer epidemiology, ... more

HIV and cervical cancer infographic

UNAIDS (2022) C_WHO

Human Papilloma Virus (HPV) is the most common sexually transmitted infection, and two types of HPV (16 and 18) cause nearly 50% of high-grade cervical ... more

WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
recommended

World Health Organization WHO (2021) C_WHO

2nd edition, July 2021. This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of c ... more

Provision of cervical cancer services for women living with HIV, Uganda

World Health Organisation (WHO) (2024) C_WHO

Cervical cancer is a disease of the female reproductive tract caused primarily by oncogenic types of human papillomavirus (HPV). In 2020, it was the fourth most common ... more

Plan of Action for Cervical Cancer Prevention and Control 2018-2030

Pan American Health Organization (PAHO) (2018) C_WHO

This Plan envisions a future with the elimination of cervical cancer as a public health problem as a result of universal access to sexual health and ... more

User manual for WHO cervical cancer prevention and control costing tool: HPV vaccination module (‎C4P-HPV tool)

World Health Organisation (WHO) (2023) C_WHO

Cervical cancer is the fourth most common cancer in women worldwide in 2018, with 570,000 new cases and ... more

Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact: web annex H: HIV care and treatment patient card

World Health Organization WHO (2022) C_WHO

The updated guidelines present a standard minimum dataset, priority indicators and recommendations to strengthen data use across HIV prevention, testing a ... more

Coping with Cancer: A Booklet für Cancer Patients

American Cancer Society; Uganda Cancer Society; John Hopkins Center for Communication Programs; et al. (2016)

Contains many illustrations of all country materials – of risk factors, treatment procedures, side effects, coping, healthy lifestyle, and more; Promotes cancer screening, especially for breast ... more

Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact

World Health Organization WHO (2022) C_WHO

The updated guidelines present a standard minimum dataset, priority indicators and recommendations to strengthen data use across HIV prevention, testing a ... more

A Textbook of Gynecology for Less-Resourced Locations

Heleen van Beekhuizen and Regine Unkels The Global Library of Women’s Medicine by Sapiens Publishing (2012)

This textbook seeks to support various levels of health personnel in less-resourced locations by providing evidence-based information about low-tech diagnostic and treatment options for common gynecological conditions such as ... more

Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study

Miti, S.; Shato, T.; Asante, C. et al. (2023) CC

PLoS ONE 18(5): e0285031. https://doi.org/10.1371/journal.pone.0285031 The study aims to integrate HPV vaccination into routine care in adolescent HIV clinics. To achieve success, we will co-design a package of implementation strategies using a pre ... more

Cervical Cancer Prevention and Control Policy (South Africa)

Dept. of Health, Republic of South Africa (2021) C1

Cervical cancer, along with maternal deaths, has been identified as a national priority in South Africa as well as other Sub-Saharan African countries. C ... more

Introducing and scaling up testing for human papillomavirus as part of a comprehensive programme for prevention and control of cervical cancer

World Health Organization WHO (2020) C_WHO

This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer p ... more

WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention

Green Ink World Health Organization (2013)

Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that may exist at any one of three stages: CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to ... more

Breast and cervical cancer screening services in Malawi: a systematic review

Pittalis, C.; Panteli, E.; Schouten, E. et al. BMC (2020) CC2

To identify and to assess factors enhancing or hindering the delivery of breast and cervical cancer ... more

Guideline for Cervical Cancer Prevention and Control in Ethiopia

Federal Ministry of Health, Ethiopia (2015) C1

Comprehensive cervical cancer prevention and control

World Health Organization (2013) C_WHO

This WHO Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control ... more

Training of community health workers: Cervical cancer screening and management of cervical pre-cancers

Lakhbir Dhaliwal, Vanita Suri, Reshmi Bagga et al. World Health Organisation (WHO) (2017) C_WHO

Cervical cancer is the second most common cancer among women worldwide and causes a sig ... more

Expanding the Single-Visit Approach for Cervical Cancer Prevention: Successes and Lessons From Burkina Faso

Ouedraogo Y., Furlane G., Fruhauf T. et al. Global Health: Science and Practice (2018) CC

Background: Cervical cancer accounts for 23% of cancer incidence and 22% of ... cancer mortality among women in Burkina Faso. These proportions are more than 2 and 5 times higher than those of developed countries, respectively. Before 2010, cervical cancer prevention (CECAP) services in Burkina Faso were limited to temporary screening campaigns. Program Description: Between September 2010 and August 2014, program implementers collaborated with the Ministry of Health and professional associations to implement a CECAP program focused on coupling visual inspection with acetic acid (VIA) for screening with same-day cryotherapy treatment for eligible women in 14 facilities. Women with larger lesions or lesions suspect for cancer were referred for loop electrosurgical excision procedure (LEEP). The program trained providers, raised awareness through demand generation activities, and strengthened monitoring capacity. Methods: Data on program activities, service provision, and programmatic lessons were analyzed. Three data collection tools, an individual client form, a client registry, and a monthly summary sheet, were used to track 3 key CECAP service indicators: number of women screened using VIA, proportion of women who screened VIA positive, and proportion of women screening VIA positive who received same-day cryotherapy. Results: Over 4 years, the program screened 13,999 women for cervical cancer using VIA; 8.9% screened positive; and 65.9% received cryotherapy in a single visit. The proportion receiving cryotherapy on the same day started at a high of 82% to 93% when services were provided free of charge, but dropped to 51% when a user fee of $10 was applied to cover the cost of supplies. After reducing the fee to $4 in November 2012, the proportion increased again to 78%. Implementation challenges included difficulties tracking referred patients, stock-outs of key supplies, difficulties with machine maintenance, and prohibitive user fees. Providers were trained to independently monitor services, identify gaps, and take corrective actions. Conclusions: Following dissemination of the results that demonstrated the acceptability and feasibility of the CECAP program, the Burkina Faso Ministry of Health included CECAP services in its minimum service delivery package in 2016. Essential components for such programs include provider training on VIA, cryotherapy, and LEEP; provider and patient demand generation; local equipment maintenance; consistent supply stocks; referral system for LEEP; non-prohibitive fees; and a monitoring data collection system. more